DCF Advisers »

Immuneering Corp - Class A shares owned by DCF Advisers

Quarter-by-quarter ownership of Immuneering Corp - Class A (IMRX) shares owned by DCF Advisers from 13F filings

Historical chart of DCF Advisers investment in Immuneering Corp - Class A

Tip: Access up to 7 years of quarterly data

All positions including Immuneering Corp - Class A held by DCF Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immuneering Corp - Class A by DCF Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.4M 215k 6.58

More positions owned by DCF Advisers

Micron Technology (MU)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Alphabet Cap Stk Cl C (GOOG)
Teva Pharmaceutical-sp Adrs (TEVA)
Argenx Se Sponsored Adr (ARGX)
Vaneck Vectors Gold Miners Etf Etf (GDX)
Eli Lilly & Co. (LLY)
Ionis Pharmaceuticals (IONS)
Ishares Gold Tr Ishares New (IAU)
Regeneron Pharmaceuticals (REGN)
Amazon (AMZN)
Bank of America Corporation (BAC)
Advanced Micro Devices (AMD)
Cybin Com New (HELP)
Newamsterdam Pharma Company Ordinary Shares (NAMS)

View all positions for DCF Advisers

Top funds holding Immuneering Corp - Class A

FMR
Sanofi
Empery Asset Management
Vanguard Group
State Street Corporation
BlackRock
Citadel Advisors
Marshall Wace
Blue Owl Capital Holdings
Geode Capital Management
Goldman Sachs Group
Burkehill Global Management
Southport Management
Diametric Capital
Millennium Management

View all funds holding Immuneering Corp - Class A